Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group
Orchard, Sandra, Al-Lazikani, Bissan, Bryant, Steve, Clark, Dominic, Calder, Elizabeth, Dix, Ian, Engkvist, Ola, Forster, Mark, Gaulton, Anna, Gilson, Michael, Glen, Robert, Grigorov, Martin, Hammond-Volume:
11
Langue:
english
Pages:
1
Journal:
Nature Reviews Drug Discovery
DOI:
10.1038/nrd3503-c2
Date:
August, 2012
Fichier:
PDF, 74 KB
english, 2012
File converter
Plus de résultats de recherche
More benefits 
